Amphion Innovations plc

Shares Issued for Exercised Warrants

London and New York, 7 April 2015 - Amphion Innovations plc (LSE: AMP) (“Amphion” or the “Company”), the developer of medical and technology businesses, today announces that the Company has issued 15,239,477 ordinary shares of 1 pence each (“Ordinary Shares”) to YA Global Master SPV, Ltd, Ashworth Global Investments Limited, and Global Market Neutral Strategies SICAV plc in settlement of their exercise of warrants that were issued in conjunction with the loan facility, previously announced on 5 June 2014, at exercise prices between 3.5 and 4.375 pence per Ordinary Share for total proceeds to the Company of £580,842.62.  There are no remaining Amphion warrants exercisable under the loan facility.  The new Ordinary Shares to be issued represent 9.11% of the enlarged issued share capital.

Admission to trading on AIM (“Admission”) of the 15,239,477 new Ordinary Shares, which rank pari passu with the existing Ordinary Shares, has been applied for, and it is expected that Admission will become effective and dealings in the new Ordinary Shares will commence on 10 April 2015.  Following this allotment the total issued share capital of the Company will increase to 167,309,343 Ordinary Shares with each share holding one voting right.

For further information please contact

Amphion Innovations
Charlie Morgan
+1 212 210 6224

Yellow Jersey PR
Dominic Barretto / Fiona Walker
+44 7768 537 739

Panmure Gordon Limited
Freddy Crossley / Fred Walsh (Corporate Finance)
Charlie Leigh-Pemberton (Corporate Broking)
+44 020 7886 2500

About Amphion Innovations plc
Amphion Innovations is a developer of medical, life science and technology businesses.

We use our extensive experience in company building to invest and build shareholder value in high growth companies in the US and UK. Amphion has significant shareholding in 7 Partner Companies developing proven technologies targeting substantial commercial marketplaces. The Amphion model has been refined to optimise the commercialisation of patents and other intellectual property within the Partner Companies. The Partner Companies collectively own or control over 200 separately identified pieces of intellectual property, a number which grows rapidly each year.

On the web: